Section Arrow
OMCL.NASDAQ
- Omnicell
Quotes are at least 15-min delayed:2025/06/06 04:17 EDT
Last
 30.88
-0.41 (-1.31%)
Day High 
31.31 
Prev. Close
31.29 
1-M High
31.56 
Volume 
466.31K 
Bid
30.72
Ask
31.33
Day Low
30.73 
Open
31.17 
1-M Low
22.66 
Market Cap 
1.47B 
Currency USD 
P/E 68.02 
%Yield -- 
10-SMA 29.61 
20-SMA 28.44 
50-SMA 30.53 
52-W High 55.745 
52-W Low 22.66 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
0.46/4.79
Enterprise Value
1.66B
Balance Sheet
Book Value Per Share
26.84
Cash Flow
Cash Flow Yield
0.11
Income Statement
Total Revenue
1.11B
Operating Revenue Per Share
25.32
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
HCTIHealthcare Triangle0.0066-0.0005-7.04%-- 
TEMTempus AI Inc.58.695-4.085-6.51%-- 
TDOCTeladoc Health6.93-0.19-2.67%-- 
TXG10x Genomics9.11-0.23-2.46%-- 
DOCSDoximity57.34+2.77+5.08%49.16PE
Quotes are at least 15-min delayed:2025/06/06 04:17 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.